Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing getmixapp
        
            Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing getmixapp
		
		
			A screen of the ReFRAME library of approximately 12,000 known drugs for antiviral activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) identified several candidate compounds with suitable activities and pharmacological profiles, which could potentially expedite the deployment of therapies for coronavirus disease 2019 (COVID-19).
		
		
	
        You've added this content to your favorites.
        
    
                    
                    
                        Post your comment
                    
                
	Load More